Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

Generated: May 27, 2017

DrugPatentWatch Database Preview

Dexrazoxane hydrochloride - Generic Drug Details

« Back to Dashboard

What are the generic sources for dexrazoxane hydrochloride and what is the scope of dexrazoxane hydrochloride freedom to operate?

Dexrazoxane hydrochloride
is the generic ingredient in three branded drugs marketed by Pharmacia And Upjohn, Gland Pharma Ltd, Clinigen Hlthcare, Mylan Institutional, and West-ward Pharms Int, and is included in five NDAs. There are two patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Dexrazoxane hydrochloride has nineteen patent family members in sixteen countries.

There are six drug master file entries for dexrazoxane hydrochloride. Three suppliers are listed for this compound.

Summary for Generic Name: dexrazoxane hydrochloride

Drug Master File Entries: see list6
Suppliers / Packagers: see list3
Bulk Api Vendors: see list29
Clinical Trials: see list1,004
Patent Applications: see list260
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:dexrazoxane hydrochloride at DailyMed

Pharmacology for Ingredient: dexrazoxane hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Gland Pharma Ltd
dexrazoxane hydrochloride
INJECTABLE;INJECTION207321-001Nov 28, 2016APRXNoNo► Subscribe► Subscribe
West-ward Pharms Int
dexrazoxane hydrochloride
INJECTABLE;INJECTION076068-001Sep 28, 2004APRXNoNo► Subscribe► Subscribe
Pharmacia And Upjohn
dexrazoxane hydrochloride
INJECTABLE;INJECTION020212-002May 26, 1995APRXYesYes► Subscribe► Subscribe
West-ward Pharms Int
dexrazoxane hydrochloride
INJECTABLE;INJECTION076068-002Sep 28, 2004APRXNoNo► Subscribe► Subscribe
Mylan Institutional
dexrazoxane hydrochloride
INJECTABLE;INJECTION200752-001Oct 19, 2011APRXNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Predict branded drug patent expiration
  • Formulary management
  • Drug patents and clinical trials in dozens of countries

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:

Google Plus